Weill Cornell Mantle Cell Lymphoma (MCL) Program 

Weill Cornell Medicine is recognized world-wide leader in mantle cell lymphoma research and treatment. Mantle cell lymphoma is a rare type of lymphoma, and at the Weill Cornell Lymphoma Program, our team of clinicians has niche expertise in caring for these patients. We also have a specialized research program dedicated to finding the best possible treatment for every single mantle cell lymphoma patient. Our experts utilize precision medicine and cutting-edge technologies to tailor treatments to the biological characteristics of each patient’s tumor. Learn more about why people with mantle cell lymphoma come from all over the world to our treatment center.